Issue Cover

Digital

Latest updates on the digital side of the pharmaceutical industry

Articles

FDA approves skin cancer AI detection device
FDA approves skin cancer AI detection device

DermaSensor has announced that the FDA has granted clearance for its real-time, non-invasive skin cancer evaluation system.

7 February 2024Digital
Digital healthcare platform launched by Eli Lilly
Digital healthcare platform launched by Eli Lilly

Eli Lilly has announced its new digital healthcare experience, LillyDirect, which will benefit patients in the US with obesity, migraine and diabetes. This is intended to offer resources around disease management, such as access to healthcare providers, tailored support and delivery of selected medications.

7 February 2024Digital
NICE recommends nine digital treatment options for depression and anxiety
NICE recommends nine digital treatment options for depression and anxiety

The National Institute for Health and Care Excellence (NICE) has recommended six digitally enabled therapies for adult patients with anxiety disorders and three digitally enabled therapies for adult patients with depression for use within the NHS while further data is gathered.

2 July 2023Digital
Servier and Aitia enter into R&D collaboration for pancreatic cancer using Digital Twins
Servier and Aitia enter into R&D collaboration for pancreatic cancer using Digital Twins

French pharmaceutical company Servier and US-based causal AI and digital twins company Aitia have announced a collaboration to create digital twins as an aid to help treat pancreatic cancer. This collaboration builds on a previous multiple myeloma one that was announced in 2022.

2 July 2023Digital
Bristol Myers Squibb and Viz.ai sign multi-year partnership for HCM device
Bristol Myers Squibb and Viz.ai sign multi-year partnership for HCM device

Bristol Myers Squibb and Viz.ai, an AI-powered medical imaging company, have signed a deal to use AI to detect and triage patients with suspected hypertrophic cardiomyopathy (hcm).

2 April 2023Digital
Sooma receives FDA Breakthrough Device designation for depression therapy device
Sooma receives FDA Breakthrough Device designation for depression therapy device

Finnish company Sooma medical has received breakthrough device designation by the FDA for its portable, at-home neuromodulation device to treat depression.

2 April 2023Digital
Elon Musk’s Neuralink rejected by FDA for human trials
Elon Musk’s Neuralink rejected by FDA for human trials

The FDA has reportedly rejected a bid by Elon Musk’s Neuralink in which it proposed the initiation of human testing for its brain chip implants. The company has been working on brain implants that allow for a computer-brain interface, which could allegedly restore vision to the blind and help paralysed people to walk again.

2 April 2023Digital
AI Finds Liver Cancer Drug Candidate In Only 30 Days
AI Finds Liver Cancer Drug Candidate In Only 30 Days

A team of scientists have broken records with their new AI which has found a novel drug candidate for liver cancer in only 30 days

6 March 2023Digital
DrugBAN AI Expected To Reduce Costs And Speed Up Drug Discovery
DrugBAN AI Expected To Reduce Costs And Speed Up Drug Discovery

A new AI has been developed to deliver medicines at a faster rate and lower cost

6 March 2023Digital
BD Showcases New-generation Robotic Track System For Microbiology Labs
BD Showcases New-generation Robotic Track System For Microbiology Labs

Becton, Dickinson and Company has revealed its new-generation robotic track system

6 March 2023Digital
AI Model Predicts CVD Risk From Single Chest Radiograph
AI Model Predicts CVD Risk From Single Chest Radiograph

A recently developed AI model has been shown to predict ten-year incidences with a similar level of success to the current standard of care.

1 February 2023Digital
Anumana And Pfizer Team Up On AI-enabled ECG Algorithm For Detection Of Cardiovascular Disease
Anumana And Pfizer Team Up On AI-enabled ECG Algorithm For Detection Of Cardiovascular Disease

Anumana, an AI-driven health technology firm, has signed a multi year deal with Pfizer in order to develop an AI electrocardiogram (AI-ECG) for the early detection of cardiac amyloidosis.

1 February 2023Digital